Human Health

Stuecker 4 tn.jpg
In the field of Human Health, several research groups at the PSI are involved in research into fundamental questions in biology and the treatment of cancer. To this end, they are studying the structure of proteins – highly complex biomolecules that are responsible for countless processes in living organisms. Patients with specific types of cancer are treated with proton therapy at the institute. The radio pharmacy is developing drugs aimed at very small tumours that have spread throughout the body.

Read more at: Human Health

28 February 2019

teaser picture

Children are her passion

Media Releases Medical Science Human Health Proton Therapy

At PSI, Beate Timmermann built up a programme providing proton therapy for children with cancer at the same time she was raising her own son. Today she is head of the Clinic for Particle Therapy at the West German Proton Therapy Centre in Essen (WPE) and is considered one of the most accomplished experts in this field.

11 October 2018

teaser picture

Licence agreement with Swiss pharma firm for development of a cancer drug

Medical Science Human Health Radiopharmacy Industrial co-operation

A radioactive agent, developed at the Paul Scherrer Institute PSI to fight an especially malignant form of thyroid cancer, has the potential to become a blockbuster drug. Due to its structure, it might also be able to dock onto cells of other tumours and destroy them with its radiation. The Lausanne-based biopharmaceutical company Debiopharm wants to further develop the PSI agent to the point where it is approved as a drug. Debiopharm and PSI have now created the contractual basis for this.

10 October 2018

teaser picture

This time, it's all bio: SwissFEL makes protein structures visible

Media Releases Biology Human Health SwissFEL

For the development of new medicinal agents, accurate knowledge of proteins is crucial. In a pilot experiment, researchers have now, for the first time, used the X-ray free-electron laser SwissFEL of PSI for the examination of protein crystals.

22 August 2018

teaser picture

A biotechnological revolution

Biology Medical Science Human Health Radiopharmacy

Gebhard Schertler is head of the research division Biology and Chemistry at the Paul Scherrer Institute PSI and professor for Structural Biology at ETH Zurich. In this interview he talks about biological research at PSI and the future of drug development.

28 May 2018

teaser picture

Imaging the inside of injection needles with neutrons

Media Releases Human Health Research Using Neutrons

Researchers from the Paul Scherrer Institute PSI, the University of Basel and Roche have used neutron imaging to investigate why cool storage is crucial for syringes pre-filled with a liquid medication.

16 May 2018

teaser picture

Light for biomolecules and super-fast processes

Media Releases Research Using Synchrotron Light Materials Research Matter and Material Biology Medical Science Human Health SwissFEL Industrial co-operation

The 16th of May is the International Day of Light. The research carried out with light at PSI enables advances in biology and pharmacology and also promotes the development of new materials for data storage and new technologies for personalised medicine.

14 May 2018

teaser picture

Opening: Advanced technology against cancer

Media Releases Medical Science Human Health Proton Therapy

With proton therapy, certain tumours can be irradiated with exceptional precision – while, the surrounding healthy tissue is optimally protected. In Switzerland, this kind of radiation therapy is only possible at PSI. In a joint project with the University Hospital Zurich and the University of Zurich, PSI has expanded its capacity with a state-of-the-art treatment facility: the new, 270-ton Gantry 3.

27 February 2018

teaser picture

Lausanne-Villigen return

Human Health Matter and Material Proton Therapy

Nowhere in the world have so many ocular tumours been irradiated with protons as at PSI. But before the affected patients go to Villigen, they have to visit Lausanne: for pretreatment at the Jules Gonin Ophthalmic Hospital. The more than 30-year-long collaboration between the hospital and PSI is unique, and in most cases it saves the patient's diseased eye.

17 November 2017

teaser picture

PSI spin-off GratXray wins Swiss Technology Award 2017

Research Using Synchrotron Light Human Health

A spin-off from PSI has received this year's Swiss Technology Award: The young company GratXray is developing a new method for early diagnosis of breast cancer.

8 November 2017

teaser picture

A new bio-robot

Media Releases Biology Human Health Industrial co-operation Radiopharmacy

With a new method for modifying antibodies, Philipp Spycher, winner of a Founder Fellowship at the Paul Scherrer Institute PSI, wants to develop drugs that are more stable and, thus, have fewer side-effects.

3 August 2017

teaser picture

Testing the Limits for the Patients’ Benefit

Human Health Medical Science Proton Therapy

Proton therapy is already a success story at the Paul Scherrer Institute PSI but researchers remain dedicated to making treatment faster and safer.

7 June 2017

teaser picture

Big help for small children

Human Health Medical Science Proton Therapy

When small children develop cancer, the whole family is affected. Staff at the Paul Scherrer Institute PSI’s Centre for Proton Therapy combine target-oriented proton beam irradiation and a caring, warm-hearted atmosphere to help these children.

27 April 2017

teaser picture

Getting a Handle on Safety

Medical Science Human Health Proton Therapy

Proton beams don’t just cure cancer. They can also damage healthy tissue. To make sure that this doesn’t happen, PSI’s Centre for Proton Therapy carries out over 350 safety tests a year. The results speak for themselves: several thousand patients have undergone proton irradiation treatment here in Villigen. There’s never been an accident.

14 March 2017

teaser picture

Rays of hope for patients

Medical Science Human Health Proton Therapy

For over 30 years, patients with a particular form of ocular tumour have been treated at PSI by means of proton irradiation. The tiny particles hit their target with millimetre precision, without endangering other structures of the eye. The irradiation facility OPTIS, developed at the PSI Center for Proton Therapy of the PSI, is a success story, considering that for more than 90 percent of the patients treated to date, the eye could be saved.

23 February 2017

teaser picture

In start-up companies, getting it done is a matter of survival

Biology Medical Science Human Health

A pharmaceuticals manager at Roche for a long time, now he is the founder of a biotech firm on the campus of the Paul Scherrer Institute PSI: Michael Hennig knows the trends in the medical sector. In this interview he explains why the medicine of the future needs the innovation power of publicly funded research, and why he chose to locate his start-up leadXpro so close to PSI.

31 January 2017

teaser picture

In cold water

Human Health Medical Science Biology

Martin Ostermaier wanted to break out of the comfort zone of science. Now, instead of pipettes, the biochemist is dealing with investors and patent law.

19 January 2017

teaser picture

Added value for cancer patients

Human Health Medical Science Proton Therapy

At the Paul Scherrer Institute PSI, cancer patients receive a treatment that is unique in Switzerland: proton therapy. This state-of-the-art form of radiation therapy against cancer has major advantages, compared to conventional irradiation, in terms of effectiveness and side-effects. The PSI has its own Center for Proton Therapy dedicated to this special treatment. Its pioneering work has not only helped several thousand patients, but also has fundamentally changed proton therapy worldwide.

12 December 2016

teaser picture

In the focus of the protons

Medical Science Human Health Radiopharmacy

At the PSI, researchers work with radioactivity every day in order to develop advanced treatment methods for patients. Naturally, they take special safety precautions working with a material that decays. It's a race against time. To make sure everything functions smoothly, a dedicated work group takes care of the infrastructure.

8 December 2016

teaser picture

Back to life

Medical Science Human Health Proton Therapy

Doctors had discovered, behind Gabi Meier’s right eye, a tumour that surrounded the optic nerve. Only at the PSI was there still one possibility to treat the tumour in such a way as to preserve neighbouring structures and the eye. A few months after the proton treatment was over, I realised that I could see more and more, she said in an interview. “Just dimly, it’s true, but I could see! That was sensational!”

25 November 2016

teaser picture

20 years of high-precision combat against cancer

Medical Science Human Health Proton Therapy

On 25.11.1996, at the Paul Scherrer Institute PSI, the world’s first cancer patient was treated with a new irradiation method: the so-called spot-scanning technique for proton beams. What’s special about it: The beam has its effect only at the depth where the tumour is located; healthy tissue above and below it is preserved. The method, developed by PSI researchers, was a breakthrough at the time and quickly became a successful product.

22 August 2016

teaser picture

Catching proteins in the act

Media Releases Large Research Facilities SwissFEL Biology Human Health

Proteins are indispensable building blocks of life. They play a vital role in many biological processes. Researchers have now been able to show how the ultrafast processes by which proteins do their work can be studied with free-electron X-ray lasers such as SwissFEL at the Paul Scherrer Institute PSI. Free-electron X-ray lasers generate extremely short and intense pulses of X-ray light. Currently there are just two such facilities in operation, worldwide. The results were published in the scientific journal Nature Communications.

26 July 2016

teaser picture

Designer nuclide for medical applications

Medical Science Human Health Radiopharmacy

Researchers at the PSI have for the first time used a cyclotron to produce the radionuclide scandium-44 in a quantity and concentration as needed for medical treatment. With that, they have achieved the first precondition for scandium-44 to be used one day for medical tests in hospitals.

29 June 2016

teaser picture

To starve a tumour

Human Health Biology

PSI researcher Kurt Ballmer-Hofer is concerned with the question of how tumours could be starved by preventing the development of blood vessels. After 40 years of research that yielded many fundamental insights about the formation of blood vessels, one of the key molecules has been found; further research is expected to enable clinical applications.

6 May 2016

teaser picture

Experiment in a hovering droplet

Media Releases Research Using Synchrotron Light Biology Human Health

At the PSI, the exact structure of proteins is deciphered in the standard way, with X-rays. Now two PSI researchers have used a clever trick to advance this method further: Instead of pinning down the proteins, they are studying them within a levitating drop of liquid.

21 April 2016

teaser picture

Hitting cancer from the inside

Medical Science Human Health Radiopharmacy

Researchers at the Paul Scherrer Institute PSI are now investigating a new method to channel radioactive substances directly into the nucleus of a cancer cell. Through this approach, the radiation source remains inside the cell and works in a more targeted way, because it gets closer to the cell's genetic information.

3. March 2016

teaser picture

Medicines made to order with pinpoint precision

Medical Science Human Health Radiopharmacy

At PSI, scientists are developing new medicines against cancer. These contain radioactive substances that can be injected into the patients and thus make their way to the tumour. There, in direct contact, their radiation should destroy the cancer cells. Before such a radioactive medicine can be tested on patients in the first clinical trials, however, its safety must be guaranteed to ensure that the patient will not be harmed. Therefore every agent is produced at the PSI under sterile conditions and tested – separately for each patient, and only on the doctor's order.

17. February 2016

teaser picture

Developing a new drug against thyroid cancer

Medical Science Human Health Radiopharmacy

Researchers at the Paul Scherrer Institute PSI have developed a drug to trace and treat a particularly malignant strain of thyroid cancer more effectively. One advantage of the new drug is that it can be used to treat a strain of thyroid cancer where the established treatment is ineffective. The researchers at PSI have developed the new drug to such an extent that an initial study conducted on cancer patients at the University Hospital Basel can now get underway.

3. February 2016

teaser picture

Probing what sets the heart racing

Media Releases Biology Human Health Medical Science

New insights into the workings of important drug receptors
Many medical drugs operate on specific receptors located in the outer walls of our body’s cells. One of these is called the beta-1 adrenergic receptor. Among other things, it is responsible for palpitation, the racing pulse that we feel with stage fright or infatuation. How it transmits signals to the cellular interior can now be revealed in detail. These findings could help scientists better understand many drugs' mode of action.

14. January 2016

teaser picture

Targeting cancer

Medical Science Human Health Radiopharmacy

There are tumours where nothing seems to help: not chemotherapy, not external radiation therapy, not an operation. Often, they have already metastasised and can no longer be destroyed using conventional methods. The only option left here is internal radiotherapy with targeted radioactive drugs that strike directly at the heart of the disease. In order to make this possible, twenty specialists have been conducting research at the Centre for Radiopharmaceutical Sciences at the Paul Scherrer Institute PSI, a joint facility of PSI, ETH Zurich and the University Hospital Zurich.

19. November 2015

teaser picture

3D nanostructure of a bone made visible

Media Releases Biology Research Using Synchrotron Light Human Health

Bones are made up of tiny fibres that are roughly a thousand times finer than a human hair. Researchers at the Paul Scherrer Institute PSI have developed a new computer-based algorithm with which they were able to visualize the localised order and alignment of these nanostructures inside an entire piece of bone for the first time.

19. October 2015

teaser picture

Robust X-ray machine for developing countries

Medical Science Biology Human Health

The Paul Scherrer Institute PSI is involved in a project conducted by several research institutes (spearheaded by EPFL) to devise an X-ray machine especially for developing countries. The device should be able to cope with tropical climes and be easy and cheap to repair. PSI researchers are focusing on producing a cost-effective detector that is necessary for the imaging. The detector registers the X-ray light much like a chip in a digital camera.

10. August 2015

teaser picture

New details of the transmission of stimuli in living organisms unveiled

Media Releases Biology Human Health Medical Science

Researchers unveil new details of how cells in a living organism process stimuli. So-called G-proteins, which help conduct external stimuli that reach a cell into its interior, play a central role here. For the first time, the study shows which parts of the G-proteins are vital for their function. Researchers from the Paul Scherrer Institute PSI, ETH Zurich, the pharmaceutical company Roche and the British MRC Laboratory of Molecular Biology report their results in the journals Nature and Nature Structural and Molecular Biology.

21. July 2015

teaser picture

Fighting tumours with protons

Human Health Medical Science Proton Therapy

Interview with Damien Charles Weber
Damien Charles Weber has been the head and chief physician of the Centre for Proton Therapy, the only centre of its kind in Switzerland, since 2013. In this interview, he talks about the successes of proton therapy in cancer treatment and the objectives for the next few years in this field.

26. May 2015

teaser image

Together, not alone

Research Using Synchrotron Light Large Research Facilities SwissFEL Human Health

Decoding biomolecules at SwissFEL and SLS
Proteins are a coveted but stubborn research object. A method developed for x-ray free-electron lasers and PSI’s future SwissFEL should now help researchers to make good headway in this field. It involves x-raying many small, identical protein samples consecutively at short intervals, thereby avoiding the main problem that protein research has faced thus far: producing samples in a sufficient size.

15. May 2014


Phase contrast improves mammography

Media Releases Medical Science Human Health

Phase contrast X-ray imaging has enabled researchers at ETH Zurich, the Paul Scherrer Institute (PSI) and the Kantonsspital Baden to perform mammographic imaging that allows greater precision in the assessment of breast cancer and its precursors. The technique could improve biopsy diagnostics and follow-up.

3. December 2013


An infection tool with a metallic core

Human Health Biology Research Using Synchrotron Light

Thanks to the analysis of protein samples at the PSI, Lausanne researchers have managed to demonstrate which instrument bacteria use to transmit diseases
Researchers from ETH Lausanne EPFL have described how a particular strain of bacteria transmits diseases with unprecedented precision. The team of scientists headed by Petr Leiman, an assistant professor at the EPFL’s Laboratory of Structural Biology and Biophysics, demonstrated that the tip of a bacterial infection tool consists of a PAAR protein, which envelops a metal atom and tapers off to a sharp point. The findings are based on measurements carried out at the Swiss Light Source (SLS), one of the three large research facilities at the Paul Scherrer Institute (PSI).

17. November 2013


How botox binds to neurons

Media Releases Biology Research Using Synchrotron Light Human Health

Botox is a highly dangerous toxin that causes paralysis. In cosmetic applications it is used to temporarily eliminate wrinkles and in medicine as a treatment for migraine or to correct strabismus. An international research team has now established how the toxin molecule binds to the neuron whose activity is then blocked by the poison. The findings may be useful for the development of improved drugs with a lower risk of overdosage.

24. October 2013


A promising new method for the diagnosis of breast cancer

Media Releases Medical Science Human Health

A new mammography procedure that could generate substantial added value for the diagnosis of breast cancer in medical practice has just been published in the scientific journal “Investigative Radiology”. The method was developed at PSI in cooperation with the Certified Breast Centre at the Kantonsspital (cantonal hospital in) Baden and Philips as an industrial partner and is making the tiniest tissue changes visible. This has the potential to improve the early detection of breast cancer. Further studies in women suffering from breast cancer are to prove in a definitive manner the added value of the method.

10. October 2013


Vitamins join fight against cancer

Human Health Medical Science

Cristina Müller, from the Center of Radiopharmaceutical Sciences at Paul Scherrer Institute (PSI), is researching a cancer therapy with radioactively labelled folate compounds. These enter the tumour cell unimpeded like a Trojan horse which is then killed as a consequence of emitted particle-radiation she explains.

29. July 2013


Pancreas: new procedure detects tumours more efficiently

Media Releases Medical Science Human Health

Better than CT and MRI: researchers at the Inselspital Berne, the University Hospital Basel and the Paul Scherrer Institute have devised a new method to detect small tumours in the pancreas.

14. February 2013


A glimpse inside the control centres of cell communication

Media Releases Biology Human Health

Numerous processes taking place within our body, such as sight, smell or taste, are accomplished by an important family of sensors on cell surfaces, which are known as G protein-coupled receptors (GPCR). Researchers have now compared the hitherto known structures of GPCRs and discovered a stabilising framework of fine struts that is characteristic for the architecture of the entire GPCR family. Knowledge about this constructional feature, which has been conserved over the course of evolution, can be of significant assistance in the development of new pharmaceuticals.

3. January 2013


How stabilised cell fibres prevent cancer cell division

Media Releases Human Health Biology Research Using Synchrotron Light

Anti-cancer drugs are used under the heading of “Chemotherapeutics” to prevent cells from dividing. Because the cells in a growing tumour divide more frequently than others, tumour cells are damaged more severely. Scientists at the Paul Scherrer Institute and the ETH Zurich have now clarified the exact mechanism of action of one class of these drugs. The data acquired is so accurate, that targeted drugs could now be developed that are even better suited to fulfil their task.

5. June 2012


Alzheimer plaques in 3D

Media Releases Human Health Research Using Synchrotron Light Biology

Researchers have succeeded in generating detailed three-dimensional images of the spatial distribution of amyloid plaques in the brains of mice afflicted with Alzheimer’s disease. The new technique used in the investigations provides an extremely precise research tool for a better understanding of the disease. In the future, scientists hope that it will also provide the basis for a new and reliable diagnosis method. The results were achieved within a joint project of two research teams – one from the Paul Scherrer Institute (PSI) and ETH Zurich, the other from the École Polytechnique Fédérale de Lausanne (EPFL).

21. December 2011


Wenn die Datenleitung in die Zelle versagt

Media Releases Human Health Biology Research Using Synchrotron Light

Lebende Zellen empfangen dauernd Informationen von aussen, die über Rezeptoren in das Zellinnere weitergeleitet werden. Genetisch bedingte Fehler in solchen Rezeptoren sind der Grund für zahlreiche Erbkrankheiten darunter verschiedene hormonelle Funktionsstörungen oder Nachtblindheit. Forschern des Paul Scherrer Instituts ist es nun erstmals gelungen, die exakte Struktur eines solchen fehlerhaften Rezeptors aufzuklären.
This news release is only available in German.

2. August 2011


Investigation of a new method for the diagnosis of cancer in breast tissue

Media Releases Human Health Medical Science

The Paul Scherrer Institute PSI has developed a new breast cancer diagnostic method, and is now carrying out first tests on non-preserved human tissue in conjunction with Kantonsspital Baden AG. This new method should be able to reveal structures that cannot be seen using conventional mammography. Scientists from the research department at Philips are currently investigating the use of this process as the basis for application in medical practice.

23. May 2011


X-ray methods help to understand brain disorders better

Media Releases Human Health Biology Research Using Synchrotron Light

An international team of researchers has developed a new method for making detailed X-ray images of brain tissue, which has been used to make the myelin sheaths of nerve fibres visible. Damage to these protective sheaths can lead to various disorders, such as multiple sclerosis. The facility for creating these images of the protective sheaths of nerve cells is being operated at the Swiss Light Source (SLS), at the Paul Scherrer Institute.

27. January 2011


Dem Rätsel der Centriolen-Bildung auf der Spur

Media Releases Human Health Biology Research Using Synchrotron Light

In menschlichen Zellen finden sich stammesgeschichtlich sehr alte Funktionseinheiten, die als Centriolen bezeichnet werden. Ein Forscherteam vom PSI und der ETH Lausanne hat nun erstmals ein Modell für die Bildung der Centriolen vorgestellt. Das erstaunende Ergebnis ist, dass die Neuner-Symmetrie des Centriols durch die Fähigkeit eines einzelnen Proteins sich selbst zu organisieren zustande kommt.
This news release is only available in French and German.

16. November 2010

20101110 Biomolecular Research 0009 tn.jpg

Effizienter Gentransfer nun auch in Säugerzellen möglich

Media Releases Human Health Biology

Wissenschaftler am Paul Scherrer Institut entwickelten ein neues Verfahren, das auch zur Entwicklung von neuen Medikamenten genutzt werden kann.
Die Gentechnik ist aus der modernen Biologie nicht mehr wegzudenken. Sie liefert Werkzeuge, mit denen Forscher Gene aus dem Erbgut von Zellen herausschneiden, verändern und einfügen können. Die stabile Einführung mehrerer Gene in Säugetierzellen gilt zwar als Schlüsseltechnologie, die verfügbaren Methoden waren bislang aber äusserst ineffizient. Wissenschaftler am PSI haben nun eine neuartige Technik entwickelt.
This news release is only available in German.

15. October 2010

101015 OPTIS2  0002 teaser.jpg

25 Jahre erfolgreiche Behandlung von Augentumoren am PSI

Media Releases Human Health Medical Science

Heute haben die Physiker und Ärzte des PSI diesen Erfolg mit einem Festsymposium gefeiert. In Anwesenheit von geladenen Gästen aus Forschung, Medizin und Politik wurde dabei auch die brandneue Behandlungsanlage OPTIS 2 eingeweiht. Diese Bestrahlungseinrichtung befindet sich nicht nur technisch auf dem allerneusten Stand, sondern überzeugt auch durch ihre Patientenfreundlichkeit.
This news release is only available in German.

23. September 2010


Advanced imaging for bone research and materials science

Media Releases Human Health Biology Research Using Synchrotron Light

High-resolution method for computed nano-tomography developed
A novel nano-tomography method developed by a team of researchers from the Technische Universität München, the Paul Scherrer Institute and the ETH Zurich opens the door to computed tomography examinations of minute structures at nanometer resolutions. The new method makes possible, for example, three-dimensional internal imaging of fragile bone structures.

22. July 2010

20100716 tomcat teaser.jpg

New X-ray technique distinguishes between that which previously looked the same

Media Releases Human Health Biology Research Using Synchrotron Light

Images generated using the phase-contrast technique allow one to distinguish between tissue types such as muscle, cartilage, tendons or soft-tissue tumours that look virtually identical in conventional X-ray images. Researchers at the Paul Scherrer Institute and the Chinese Academy of Science have further developed the technique to make it easier to use in the future. This could help in the detection of tumours or in the identification of hazardous objects in luggage.

2. July 2010

zevalin tn.jpg

Paul Scherrer Institut ermöglicht bessere Versorgung der Spitäler mit hochwirksamem Krebsmedikament

Media Releases Medical Science Human Health

Das Paul Scherrer Institut ist für die Behandlung von bestimmten Krebserkrankungen mittels seiner einzigartigen Protonentherapie-Anlage bekannt. Nun hilft das PSI auch bei der Behandlung einer Gruppe von Krebspatienten durch die Herstellung eines Krebsmedikaments. Die erste Patientendosis wurde heute am Zentrum für Radiopharmazeutische Wissenschaften des PSI hergestellt und im Kantonsspital Luzern einem Patienten verabreicht.
This news release is only available in German.

18. January 2010

MM20100119 Teaser.jpg

Attacking the lifeline of tumour cells

Media Releases Biology Research Using Synchrotron Light Human Health

Researchers at Biomedicum Helsinki, Finland, and the Paul Scherrer Institute (PSI) in Villigen, Switzerland, have determined the crystal structure of the ligand-binding domain of a vascular endothelial growth factor (VEGF) receptor in complex with one of its ligands (VEGF-C).

1. December 2009

interphase tn.jpg

Studies on protein structures – understanding the basic building blocks of life

Human Health Biology Research Using Synchrotron Light

Proteins are the building blocks of all living organisms. In the living cell these complex molecules perform countless tasks. The precise function a protein performs is directly related to its structure. Researchers at the PSI investigate a wide range of proteins, in order to understand their structures and functions, often to lay the foundations for developing new drugs. In addition, researchers explore new techniques for determining protein structure – in particular with synchrotron light at the Swiss Light Source (SLS).

24. July 2009

MM090723Fig2 tn.jpg

Ticket für die Reise durch die Zelle

Media Releases Biology Human Health Research Using Synchrotron Light

Publikation in Cell. Forscher entdecken Mechanismus für wesentliche Erkennungsvorgänge in lebenden Zellen. Über ihre Ergebnisse berichten die Forscher in der neuesten Ausgabe der Fachzeitschrift Cell.
This news release is only available in German.

4. May 2009

MM090504Multiprotein tn.jpg

Komplexe in den Griff bekommen

Media Releases Human Health Biology

Die meisten Vorgänge in lebenden Zellen werden von molekularen Maschinen aus vielen Proteinen ausgeführt. Wissenschaftler von PSI und EMBL haben ein automatisiertes Verfahren zur Herstellung von solchen Multiprotein-Komplexen für die Forschung entwickelt.
This news release is only available in German.

28. October 2008

Pfeiffer Franz 0009 tn.jpg

Röntgenbilder mit Durchblick

Media Releases Medical Science Human Health

Der Nationale Latsis-Preis 2008 geht an Franz Pfeiffer. Der Physiker hat einen Weg gefunden, die in der Spitzenforschung angewandten Verfahren der Röntgentechnik auch für gewöhnliche Röntgengeräte nutzbar zu machen. Der mit 100'000 Franken dotierte Preis wird jährlich vom Schweizerischen Nationalfonds (SNF) im Auftrag der Latsis-Stiftung vergeben.
This news release is only available in German.

5. September 2008

080905 MM mFAS spiral white tn.jpg

Promising targets for drug development

Media Releases Human Health Biology

ETH Researchers determine atomic structure of the mammalian fatty acid factory. Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is a promising target for the development of anti-cancer and anti-obesity drugs and for the treatment of metabolic disorders. Researchers of ETH Zurich have determined the atomic structure of a mammalian fatty acid synthase.

3. June 2008

080603 MM CT tn.jpg

Vitamin B12 ist das Trojanische Pferd der Krebsforscher am schweizerischen Zentrum für radiopharmazeutische Wissenschaft

Media Releases Human Health Medical Science Biology

Erste Klinische Studie soll Mitte Juni beginnen.
This news release is only available in German.

20. January 2008

MM080120 xray chickenwing darkfield tn.jpg

New technology sharpens X-ray vision

Media Releases Medical Science Biology Human Health

Publication in Nature. Researchers at the Paul Scherrer Institute (PSI) and the EPFL in Switzerland have developed a novel method for producing dark-field X-ray images at wavelengths used in typical medical and industrial imaging equipment. Dark-field images provide more detail than ordinary X-ray radiographs and could be used to diagnose the onset of osteoporosis, breast cancer or Alzheimer's disease, to identify explosives in hand luggage, or to pinpoint hairline cracks or corrosion in functional structures.
Topic Overview